Economics of TB Drug Development New Data for New Research
The Economics of TB Drug Development is a rigorous, authoritative source of information on the epidemiology of tuberculosis, potential market for new anti-TB drugs, costs of drug development, the potential return on investment, and options for funding and conducting drug development. Prepared by a variety of TB experts at public health agencies, research organisations, private pharmaceutical companies, and nongovernmental organisations (NGOs), under the auspices of the Global Alliance for TB Drug Development, this report provides essential data required for informed
investment decisions by industry, foundations, government organisations, and world.
health and financial organisations.
Rouse, D. (Ed.) (2001). Economics of TB Drug Development: New Data for New Research. New York, NY: The Global Alliance for TB Drug Development.